Integral Health Asset Management as of March 31, 2026
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 86 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines Put Option (RVMD) | 12.8 | $267M | 2.8M | 97.25 | |
| Insmed Com Par $.01 (INSM) | 11.7 | $245M | 1.5M | 163.52 | |
| Cytokinetics Com New Call Option (CYTK) | 8.2 | $171M | 2.6M | 65.91 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $66M | 85k | 772.64 | |
| Vera Therapeutics Cl A (VERA) | 3.1 | $64M | 1.6M | 40.23 | |
| Cardinal Health (CAH) | 2.7 | $57M | 270k | 211.31 | |
| Roivant Sciences SHS (ROIV) | 2.6 | $55M | 2.0M | 27.70 | |
| Brightspring Health Svcs (BTSG) | 2.5 | $53M | 1.3M | 42.61 | |
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $52M | 600k | 86.97 | |
| Merck & Co (MRK) | 2.4 | $51M | 425k | 120.29 | |
| Edgewise Therapeutics (EWTX) | 2.4 | $50M | 1.6M | 31.50 | |
| Astrazeneca Ord (AZN) | 2.4 | $49M | 250k | 197.22 | |
| Alignment Healthcare (ALHC) | 2.2 | $45M | 2.6M | 17.62 | |
| Novartis Sponsored Adr (NVS) | 1.8 | $38M | 250k | 152.75 | |
| Boston Scientific Corporation (BSX) | 1.7 | $35M | 550k | 62.75 | |
| Mineralys Therapeutics Call Option (MLYS) | 1.6 | $34M | 1.3M | 27.09 | |
| Lifestance Health Group (LFST) | 1.3 | $27M | 4.3M | 6.37 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.3 | $26M | 115k | 228.73 | |
| Scholar Rock Hldg Corp (SRRK) | 1.2 | $25M | 500k | 49.16 | |
| Anthem (ELV) | 1.1 | $22M | 75k | 292.75 | |
| Centene Corporation (CNC) | 1.0 | $21M | 650k | 32.74 | |
| Bridgebio Pharma (BBIO) | 1.0 | $20M | 275k | 74.26 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $20M | 150k | 131.74 | |
| Glaukos (GKOS) | 0.9 | $19M | 175k | 107.66 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.9 | $19M | 300k | 62.70 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $18M | 40k | 446.54 | |
| Oric Pharmaceuticals (ORIC) | 0.8 | $18M | 1.4M | 12.67 | |
| Alumis (ALMS) | 0.8 | $18M | 800k | 22.03 | |
| Fresenius Medical Care Sponsored Adr (FMS) | 0.8 | $18M | 775k | 22.56 | |
| Intuitive Surgical Com New (ISRG) | 0.8 | $16M | 35k | 460.99 | |
| Uniqure Nv SHS (QURE) | 0.7 | $15M | 900k | 16.35 | |
| Tarsus Pharmaceuticals (TARS) | 0.7 | $14M | 200k | 70.15 | |
| Gilead Sciences (GILD) | 0.7 | $14M | 100k | 139.37 | |
| Eli Lilly & Co. (LLY) | 0.7 | $14M | 15k | 919.77 | |
| Edwards Lifesciences (EW) | 0.7 | $14M | 170k | 80.08 | |
| Cogent Biosciences (COGT) | 0.6 | $14M | 350k | 38.49 | |
| Elanco Animal Health (ELAN) | 0.6 | $13M | 550k | 23.93 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $13M | 25k | 523.47 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.6 | $13M | 40k | 322.19 | |
| Dianthus Therapeutics (DNTH) | 0.6 | $13M | 150k | 83.92 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $13M | 1.5M | 8.38 | |
| Quest Diagnostics Incorporated (DGX) | 0.6 | $12M | 60k | 195.98 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $12M | 200k | 58.15 | |
| Erasca (ERAS) | 0.5 | $11M | 700k | 16.18 | |
| Alto Neuroscience Com Shs (ANRO) | 0.5 | $11M | 500k | 22.48 | |
| Biogen Idec (BIIB) | 0.5 | $11M | 60k | 183.33 | |
| Dex (DXCM) | 0.5 | $11M | 175k | 62.80 | |
| Soleno Therapeutics (SLNO) | 0.5 | $11M | 325k | 33.48 | |
| Disc Medicine (IRON) | 0.5 | $11M | 170k | 63.94 | |
| Nurix Therapeutics (NRIX) | 0.5 | $11M | 700k | 15.50 | |
| CVS Caremark Corporation (CVS) | 0.5 | $11M | 150k | 71.82 | |
| Cooper Cos (COO) | 0.5 | $11M | 150k | 71.50 | |
| Thermo Fisher Scientific (TMO) | 0.5 | $9.8M | 20k | 491.53 | |
| Livanova SHS (LIVN) | 0.5 | $9.5M | 150k | 63.56 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.5 | $9.5M | 125k | 75.85 | |
| Tango Therapeutics (TNGX) | 0.5 | $9.4M | 450k | 20.92 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $9.4M | 125k | 75.09 | |
| Sana Biotechnology (SANA) | 0.4 | $9.2M | 3.2M | 2.88 | |
| Celcuity (CELC) | 0.4 | $9.1M | 80k | 114.14 | |
| Protara Therapeutics Com Stk (TARA) | 0.4 | $9.1M | 1.8M | 5.21 | |
| Envista Hldgs Corp (NVST) | 0.4 | $8.9M | 350k | 25.37 | |
| Biohaven (BHVN) | 0.4 | $8.5M | 1.0M | 8.46 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $8.2M | 350k | 23.36 | |
| Viking Therapeutics (VKTX) | 0.4 | $8.1M | 250k | 32.54 | |
| Definium Therapeutics Com Shs (DFTX) | 0.4 | $7.6M | 400k | 18.90 | |
| Beam Therapeutics (BEAM) | 0.3 | $7.1M | 300k | 23.83 | |
| Rezolute Com New (RZLT) | 0.3 | $6.1M | 2.0M | 3.05 | |
| Capricor Therapeutics Com New (CAPR) | 0.3 | $6.1M | 200k | 30.40 | |
| Iqvia Holdings (IQV) | 0.3 | $6.0M | 35k | 170.54 | |
| Axsome Therapeutics (AXSM) | 0.3 | $5.9M | 35k | 169.02 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $5.3M | 50k | 105.40 | |
| Evommune Com Shs (EVMN) | 0.2 | $5.2M | 225k | 22.99 | |
| Acadia Healthcare (ACHC) | 0.2 | $4.7M | 200k | 23.39 | |
| Zimmer Holdings (ZBH) | 0.2 | $4.5M | 50k | 90.42 | |
| Forte Biosciences Com New (FBRX) | 0.2 | $3.9M | 150k | 25.90 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.2 | $3.7M | 150k | 24.66 | |
| Savara (SVRA) | 0.2 | $3.3M | 600k | 5.46 | |
| Relmada Therapeutics (RLMD) | 0.1 | $3.1M | 450k | 6.96 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $3.0M | 100k | 30.15 | |
| Maze Therapeatics (MAZE) | 0.1 | $3.0M | 100k | 29.85 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.7M | 167k | 15.99 | |
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $2.3M | 1.4M | 1.68 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $2.2M | 150k | 14.91 | |
| Inventiva Sa Ads (IVA) | 0.1 | $2.2M | 400k | 5.55 | |
| Sionna Therapeutics (SION) | 0.1 | $2.0M | 50k | 40.09 | |
| Unicycive Therapeutics Com New (UNCY) | 0.1 | $1.5M | 225k | 6.58 |
